Literature DB >> 7631977

Molecular/cell engineering approach to autocrine ligand control of cell function.

D A Lauffenburger1, K E Forsten, B Will, H S Wiley.   

Abstract

Tissue engineering, along with other modern cell- and tissue-based health care technologies, depends on successful regulation of cell function by molecular means, including pharmacological agents, materials, and genetics. This regulation is generally mediated by cell receptor/ligand interactions providing primary targets for molecular intervention. While regulatory ligands may often be exogenous in nature, in the categories of endocrine and paracrine hormone systems, they are being increasingly appreciated as crucial in local control of cell and tissue function. Improvements in design of health care technologies involving autocrine ligand interactions with cell receptors should benefit from increased qualitative and quantitative understanding of the kinetic and transport processes governing these interactions. In this symposium paper we offer a concise overview of our recent efforts combining molecular cell biology and engineering approaches to increase the understanding of how molecular and cellular parameters may be manipulated for improved control of cell and tissue function regulated by autocrine ligands.

Mesh:

Substances:

Year:  1995        PMID: 7631977     DOI: 10.1007/bf02584423

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  50 in total

Review 1.  Inhibitors of angiogenesis.

Authors:  M A Moses; R Langer
Journal:  Biotechnology (N Y)       Date:  1991-07

Review 2.  Structure-based strategies for drug design and discovery.

Authors:  I D Kuntz
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 3.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

4.  The growth-response of human tumor-cell lines expressing the EGF receptor to treatment with EGF and or mabs that block ligand-binding.

Authors:  H Modjtahedi; J Styles; C Dean
Journal:  Int J Oncol       Date:  1993-08       Impact factor: 5.650

Review 5.  Wound therapy: growth factors as agents to promote healing.

Authors:  W Meyer-Ingold
Journal:  Trends Biotechnol       Date:  1993-09       Impact factor: 19.536

Review 6.  Receptor cloning and heterologous expression--towards a new tool for drug discovery.

Authors:  W H Luyten; J E Leysen
Journal:  Trends Biotechnol       Date:  1993-06       Impact factor: 19.536

Review 7.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 8.  Human gene therapy.

Authors:  R A Morgan; W F Anderson
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

Review 9.  Tissue engineering by cell transplantation using degradable polymer substrates.

Authors:  L G Cima; J P Vacanti; C Vacanti; D Ingber; D Mooney; R Langer
Journal:  J Biomech Eng       Date:  1991-05       Impact factor: 2.097

Review 10.  The epidermal growth factor receptor as a target for therapy in breast carcinoma.

Authors:  J Baselga; J Mendelsohn
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

View more
  4 in total

1.  Spatial range of autocrine signaling: modeling and computational analysis.

Authors:  S Y Shvartsman; H S Wiley; W M Deen; D A Lauffenburger
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

3.  Time and length scales of autocrine signals in three dimensions.

Authors:  Mathieu Coppey; Alexander M Berezhkovskii; Stuart C Sealfon; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2007-09-15       Impact factor: 4.033

4.  Theory for ligand rebinding at cell membrane surfaces.

Authors:  B C Lagerholm; N L Thompson
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.